Leaders from ViiV Healthcare have launched a phase III program to find more supportive evidence for its dolutegravir (Tivicay) and lamivudine (Epivir) treatments, which are designed for adults with HIV-1 infections.
The National Institute of Allergy and Infectious Disease (NIAID) recently reported that people with Ebola virus infections are 20 percent more likely to overcome the infection and survive if they also had co-infections of Plasmodium parasites, which cause malaria.
The Tuberous Sclerosis Alliance (TS Alliance) recently announced that it has created the Engles Collaborative Research Fund, which will give $1.5 million to research for tuberous sclerosis complex (TSC) solutions.
Scientists with the National Institutes of Allergy and Infectious Diseases (NIAD), a branch of the National Institutes of Health (NIH), recently began a clinical trial for a vaccine candidate that is designed to stop Zika virus infections.
A team of scientists from the National Institutes of Health (NIH) recently found the genetic mutation that causes a rare kind of pediatric progressive neuropathy -- and they may have developed a therapeutic target to treat the disease.
The ALS Association and Cytokinetics Inc. recently announced that they have chosen to continue and broaden their current partnership against ALS, furthering their support of various initiatives and programs.
Leaders at AbbVie, a worldwide biopharmaceutical company, recently announced that it has launched its phase-three clinical trial concerning venetoclax, which is designed to treat patients who have relapsed or refractory multiple myeloma.
The Human Connectome Project (HCP), part of the National Institutes of Health (NIH), recently announced that its new software has mapped 180 specific regions within the brain’s cortex automatically, more than doubling the previous number.
According to the latest American Heart Association 'Rapid Access Journal Report,' evidence suggests that patients who experienced a heart attack may improve their heart function and decrease scarring by taking high omega-3 fatty acids doses via fish oil capsules for six months.
The ALS Ice Bucket Challenge first gained popularity in 2014, effectively fundraising more than $100 million to support research for treatments and cures for amyotrophic lateral sclerosis (ALS), which is also called Lou Gehrig’s disease.
The top leaders of Parent Project Muscular Dystrophy (PPMD), Hope for Gabe and the Foundation to Eradicate Duchenne recently expressed their support for the 21st Century Cures Act, promoting the related #CuresNow campaign.
Eli Lilly and Company recently announced that its latest phase-two study with tau imaging agent flortaucipir (AV -1451) shows a potential connection between tau pathology tangles and the progression of Alzheimer’s.